Abstract
Bacteria become resistant by a number of different mechanisms, and these include mutation in chromosomal genes (1), acquisition of plasmids (2), insertion of bacteriophage, transposon or insertion sequence DNA (3-5), or gene mosaicism (6). There is a dogma that bacteria that become resistant pay a significant physiological price and that if antimicrobial prescribing is controlled it will result in the eradication of resistant organisms. There are only very few studies that investigate the physiology of resistance acquisition and these do show that a physiological price is paid for this change (7, 8). Once an organism acquires resistance through mutation, acquisition of resistance genes via plasmids, transposons and bacteriophages the initial physiological defect is compensated by the antibiotic selective pressure, which balances the physiological deficit imposed by the resistant mutation or additional DNA (8, 9).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ramaswamy, S. and Musser, J. M. (1998) Molecular genetic basis of antimicrobial resistance in Mycobacterium tuberculosis: 1998 update. Tubercle. Lung Dis. 79, 3ā29.
Lenski, R. E., Simpson, S. C., and Nguyen, T. T. (1994) Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J. Bacteriol. 176, 3140ā3147.
Hyder, S. L. and Steitfeld, M. M. (1978) Transfer of erythromycin resistance from clinically isolated lysogenic strains of Streptococcus pyogenes via their endogenous phage. J. Infect. Dis. 138, 281ā286.
Poyart, C., Pierre, C., Quesne, G., Pron, B., Berche, P., and Trien-Cust, P. (1997) Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob. Agents Chemother. 41, 24ā29.
Lemaitre, N., Sougakoff, W., Truffot-Pernot, C., and Jarlier, V. (1999) Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrob. Agents Chemother. 43, 1761ā1763.
Tomasz, A. (1997) Antibiotic resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 24(Suppl. 1), 585ā588.
Gillespie, S. H. and McHugh, T. D. (1997) The biological cost of antimicrobial resistance. Trends Microbiol. 5, 337ā339.
Schrag, S. J., Perrot, V., and Levin, B. R. (1997) Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. Roy. Soc. Lond.-Series B: Biol. Sci. 264, 1287ā1291.
Billington, O., McHugh, T. D., and Gillespie, S. H. (1999) The physiological cost of rifampicin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43, 1866ā1869.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2001 The Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Gillespie, S.H. (2001). In Vitro Assessment of the Fitness of Resistant M. tuberculosis Bacteria by Competition Assay. In: Gillespie, S.H. (eds) Antibiotic Resistence. Methods in Molecular Medicineā¢, vol 48. Humana Press. https://doi.org/10.1385/1-59259-077-2:233
Download citation
DOI: https://doi.org/10.1385/1-59259-077-2:233
Publisher Name: Humana Press
Print ISBN: 978-0-89603-777-9
Online ISBN: 978-1-59259-077-3
eBook Packages: Springer Protocols